JWBC
GSK icon

J.W. Burns & Co’s GSK GSK Stock Holding History

J.W. Burns & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,412
Closed -$371K – 169
2019
Q2 		$371K Sell
7,412
-1,382
-16% -$69.3K 0.09% 131
2019
Q1 		$459K Sell
8,794
-152
-2% -$7.59K 0.11% 115
2018
Q4 		$427K Sell
8,946
-400
-4% -$19.7K 0.12% 116
2018
Q3 		$469K Sell
9,346
-268
-3% -$13.6K 0.11% 123
2018
Q2 		$484K Sell
9,614
-1,110
-10% -$55.9K 0.12% 117
2018
Q1 		$524K Sell
10,724
-4,578
-30% -$213K 0.13% 113
2017
Q4 		$678K Sell
15,302
-1,842
-11% -$85.1K 0.17% 103
2017
Q3 		$870K Sell
17,144
-1,701
-9% -$86.3K 0.23% 93
2017
Q2 		$1.02M Sell
18,845
-372
-2% -$19.8K 0.27% 86
2017
Q1 		$1.01M Sell
19,217
-841
-4% -$42.7K 0.28% 84
2016
Q4 		$966K Sell
20,058
-1,838
-8% -$90.8K 0.28% 82
2016
Q3 		$1.18M Sell
21,896
-797
-4% -$43.7K 0.36% 73
2016
Q2 		$1.23M Sell
22,693
-453
-2% -$23.9K 0.37% 75
2016
Q1 		$1.17M Buy
23,146
+4
+0% +$199 0.37% 72
2015
Q4 		$1.17M Buy
23,142
+63
+0.3% +$3.21K 0.37% 74
2015
Q3 		$1.11M Buy
23,079
+835
+4% +$43.5K 0.38% 71
2015
Q2 		$1.16M Buy
22,244
+443
+2% +$24.9K 0.38% 71
2015
Q1 		$1.26M Buy
21,801
+2,875
+15% +$165K 0.41% 66
2014
Q4 		$1.01M Buy
18,926
+544
+3% +$30.4K 0.33% 73
2014
Q3 		$1.06M Buy
18,382
+2,124
+13% +$130K 0.36% 71
2014
Q2 		$1.09M Buy
16,258
+1,479
+10% +$100K 0.36% 71
2014
Q1 		$987K Buy
14,779
+155
+1% +$10.5K 0.35% 72
2013
Q4 		$976K Buy
14,624
+366
+3% +$23.7K 0.34% 72
2013
Q3 		$894K Buy
14,258
+1,412
+11% +$90.9K 0.34% 73
2013
Q2 		$802K Buy
+12,846
New +$815K 0.33% 75

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

J.W. Burns & Co's GSK Position: Q3 2019 in Review

J.W. Burns & Co sold out of GSK (GSK) in Q3 2019, closing a stake of 7,412 shares — an estimated $371K sold.

J.W. Burns & Co first reported a position in GSK in Q2 2013 and held it in 25 quarters. The position peaked at $1.26M in Q1 2015. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • J.W. Burns & Co reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • J.W. Burns & Co sold 7,412 GSK shares in Q3 2019, an estimated $371K.
  • J.W. Burns & Co first reported a position in GSK in Q2 2013 and held it in 25 quarters.
  • J.W. Burns & Co's GSK position peaked at $1.26M in Q1 2015.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on J.W. Burns & Co's 13F filing for Q3 2019, filed 11 Oct 2019.